Skip to main content
. 2022 Sep 16;2022:3512582. doi: 10.1155/2022/3512582

Table 21.

Analysis of multiple drug resistance rate of CREs in 2019.

  Drugs Drug resistance rate (%)
CREs Ampicillin-sulbactam 97.1
  Imipenem 88.9
  Ceftriaxone 84.9
  Ertapenem 83.6
  Ceftazidime 82.7
  Nitrofurantoin 79.4
  Ciprofloxacin 78.9
  Aztreonam 77.3
  Levofloxacin 76.8
  Cefepime 75.8
  Piperacillin-tazobactam 74.5
  Cefoperazone-sulbactam 70.4
  Gentamicin 53.5
  Tobramycin 50.0
  Cotrimoxazole 43.3
  Amikacin 31.6
  Tigecycline 0.0